Spots Global Cancer Trial Database for cushing's disease
Every month we try and update this database with for cushing's disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease | NCT04339751 | Cushing's Disea... | Vorinostat | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | NCT01371565 | Cushing's Disea... Cushing's Syndr... | Mifepristone | 18 Years - | Corcept Therapeutics | |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Collecting Information About Treatment Results for Patients With Cushing's Syndrome | NCT03364803 | Cushing's Disea... Cushing Syndrom... Cushing Disease | Cushing's QoL (... Nottingham Heal... Hospital Anxiet... Perceived Stres... Barratt's Impul... Beck Depression... State-Trait Anx... State Food Crav... Trait Food Crav... Visual Analogue... Sensitivity to ... | 14 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. | NCT01582061 | Cushing's Disea... | Pasireotide sub... | 18 Years - | Novartis | |
| Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease | NCT00434148 | Cushing's Disea... | Pasireotide | 18 Years - | Novartis | |
| Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease | NCT00171951 | Cushing Disease | Pasireotide | 18 Years - | Novartis | |
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly | NCT02060383 | Cushing's Disea... Acromegaly | Pasireotide s.c... Sitagliptin Liraglutide Insulin Pasireotide LAR Metformin | 18 Years - | Novartis | |
| Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease | NCT01374906 | Cushing's Disea... | pasireotide LAR SOM230 LAR 30 m... SOM230 LAR 10 m... | 18 Years - | Novartis | |
| Cushing's Disease Complications | NCT02568982 | Cushing's Disea... | Exams and quest... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) | NCT00612066 | Cushing's Disea... | rosiglitazone m... | 18 Years - 65 Years | Jonsson Comprehensive Cancer Center | |
| Effects of Hormone Stimulation on Brain Scans for Cushing s Disease | NCT01459237 | Pituitary Neopl... | Acthrel | 8 Years - | National Institutes of Health Clinical Center (CC) | |
| SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome | NCT05307328 | Cushing's Syndr... Cushing Disease... Cortisol Excess Cortisol; Hyper... Cortisol Overpr... Ectopic ACTH Se... | SPI-62 Placebo | 18 Years - | Sparrow Pharmaceuticals | |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Disease | NCT03708900 | Cushing's Disea... | LCI699 | 6 Years - 17 Years | RECORDATI GROUP | |
| Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | NCT01371565 | Cushing's Disea... Cushing's Syndr... | Mifepristone | 18 Years - | Corcept Therapeutics | |
| Long-term Cardiovascular Risk in Cured Cushing's Patients | NCT00881283 | Cushing's Disea... | 35 Years - 55 Years | Massachusetts General Hospital | ||
| Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor | NCT00889525 | Cushing's Disea... Corticotroph Ad... | Cabergoline | 12 Years - | Seth Gordhandas Sunderdas Medical College | |
| Long-term Cardiovascular Risk in Cured Cushing's Patients | NCT00881283 | Cushing's Disea... | 35 Years - 55 Years | Massachusetts General Hospital | ||
| Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor | NCT00889525 | Cushing's Disea... Corticotroph Ad... | Cabergoline | 12 Years - | Seth Gordhandas Sunderdas Medical College | |
| Seoul National University Pituitary Disease Cohort Study | NCT03474601 | Pituitary Disea... Pituitary Incid... Acromegaly Central Diabete... Pituitary Stalk... Cushing's Disea... Pituitary Tumor Prolactinoma | Dynamic hormone... | 18 Years - | Seoul National University Hospital | |
| Collecting Information About Treatment Results for Patients With Cushing's Syndrome | NCT03364803 | Cushing's Disea... Cushing Syndrom... Cushing Disease | Cushing's QoL (... Nottingham Heal... Hospital Anxiet... Perceived Stres... Barratt's Impul... Beck Depression... State-Trait Anx... State Food Crav... Trait Food Crav... Visual Analogue... Sensitivity to ... | 14 Years - | Memorial Sloan Kettering Cancer Center | |
| An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. | NCT01582061 | Cushing's Disea... | Pasireotide sub... | 18 Years - | Novartis | |
| Preoperative Bexarotene Treatment for Cushing's Disease | NCT00845351 | Cushing's Disea... | Bexarotene | 18 Years - 65 Years | University of Virginia | |
| Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease | NCT02603653 | Cushing's Disea... | Virtual radial ... | 18 Years - 60 Years | Institut National de la Santé Et de la Recherche Médicale, France | |
| Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease | NCT04569591 | Cushing's Disea... Pituitary Adeno... | Acthrel | 8 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
